Cite
HARVARD Citation
Iannitto, E. et al. (n.d.). Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Leukemia & lymphoma. 56 (12), pp. 3281-3287. [Online].